NCT01120470: OGX-427 in Castration Resistant Prostate Cancer Patients |
|
|
| Completed | 2 | 74 | Canada, US | OGX-427, Apatorsen, Prednisone, Rayos, Sterapred | British Columbia Cancer Agency, Achieve Life Sciences | Castration Resistant Prostate Cancer | 10/12 | 06/14 | | |
NCT01848067: Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer |
|
|
| Completed | 1/2 | 9 | US | Alisertib, MLN8237, Abiraterone acetate, Abiraterone, Zytiga, Prednisone, Cortan, Deltasone, Orasone, Prednisone Intensol, Sterapred, Rayos | Sidney Kimmel Cancer Center at Thomas Jefferson University, Millennium: The Takeda Oncology Company | Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer | 03/15 | 06/16 | | |
